Relay Therapeutics, Inc.

NASDAQ:RLAY

7.86 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -92.212-81.387-83.495-65.734-98.505-94.239-67.503-84.172-76.788-62.046-67.456-60.834-193.398-42.18435.276-36.078-26.724-24.886-23.913-19.673-17.537-14.182
Depreciation & Amortization 1.3681.3951.3751.3631.3341.1971.1661.0330.9560.9751.0341.0120.960.9190.9120.9130.8650.8590.8530.6340.6910.667
Deferred Income Tax 005.077-2.876-2.201000000.6810.67-0.001000000000
Stock Based Compensation 26.83227.18819.26721.83523.41121.51813.81713.71915.14713.45510.21812.41816.1479.67114.54411.9294.0321.4551.3061.2481.0820.82
Change In Working Capital 12.8447.978-20.599-28.7859.5127.4146.37-0.3272.8462.35714.98-8.46512.74878.081-86.018-0.8111.10.559-0.3721.4261.4331.823
Accounts Receivables 000.211-0.1330.2080.02-0.0650.047-0.0190.1340.401-0.525-0.19975-750000000
Change In Inventory 0021.696-27.7896.0930000012.1-7.34912.9473.762-12.6010000000
Change In Accounts Payables 3.2050.102-5.374-1.2222.8021.41.9674.633-3.388-1.2232.433-0.636-0.056-0.8111.2832.352-1.707-2.3382.3470.1280.541-0.016
Other Working Capital 9.6397.876-37.1320.3590.4095.9944.468-5.007-0.0583.4460.0460.0450.0560.130.3-3.1632.8072.897-2.7191.2980.8921.839
Other Non Cash Items 11.69824.379-10.813-1.2-2.152-3.02-10.9293.6020.2-3.9140.8362135.4040.1530.0140.008-0.117-0.321-0.635-1.138-0.7220.056
Operating Cash Flow -65.833-50.323-89.188-75.397-68.601-67.13-57.079-66.145-57.093-49.173-39.707-53.199-28.1446.64-35.272-24.039-20.844-22.334-22.761-17.503-15.053-10.816
Investing Activities:
Investments In Property Plant And Equipment -0.011-1.78-0.118-0.59-1.503-1.915-2.316-2.095-1.857-2.794-0.88-1.736-0.379-0.476-0.064-0.433-0.414-1.02-0.598-2.387-1.873-3.144
Acquisitions Net 00-257.634-71.955-52.78-77.229144.62-29.28200-0.083-0.083-25.132000000000
Purchases Of Investments -119.634-190.784-136.815-84.752-66.16-97.815-327.641-55.833-24.255-127.69-327.032-7.394-26.919-619.32-126.358-68.994-15.494-55.609-88.98-89.537-3750
Sales Maturities Of Investments 165.195203.095196.611156.707118.94175.044183.02185.11569.518.135.253078.498386.17550.00289.5103.556107125.47599180
Other Investing Activites 45.56112.311257.63471.95552.7877.229-144.6229.28245.245-109.59-291.78222.606-25.132-233.145-76.35620.50688.06251.39136.4959.4630.020
Investing Cash Flow 45.5510.53159.67871.36551.27775.314-146.93627.18743.388-112.384-292.74520.78726.068-233.621-76.4220.07387.64850.37135.8977.076-358.853-3.144
Financing Activities:
Debt Repayment 0000000000000000000000
Common Stock Issued 1.54248.92220.9189.4582.081.297284.744285.8651.9960.883382.210.9021.1212.0550.056428.2420.3670.3510.4410.120.0230.029
Common Stock Repurchased 00000000000000-2.4510000000
Dividends Paid 0000000000000000000000
Other Financing Activities 1.54248.92219.4582.081.297-283.578285.8651.9960.8831.8020.9021.1212.0552.507-2.047-0.460.351-0.668-0.0040.6475.018
Financing Cash Flow 1.54248.92221.9189.4582.081.2971.166285.8651.9960.883384.0120.9021.1212.0550.056426.195-0.0930.351-0.2270.1160.675.047
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000
Net Change In Cash -18.7419.13-7.5925.426-15.2449.481-202.849246.907-11.709-160.67451.56-31.51-0.951-184.926-111.636422.22966.71128.38812.909-10.311-373.236-8.913
Cash At End Of Period 134.125152.866146.443154.035148.609163.853154.372357.221110.314122.023282.697231.137262.647263.598448.524560.16137.93171.2242.83229.92340.234413.47